129 related articles for article (PubMed ID: 26558960)
1. Solvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics.
Zaslavsky BY; Uversky VN; Chait A
Expert Rev Proteomics; 2016; 13(1):9-17. PubMed ID: 26558960
[TBL] [Abstract][Full Text] [Related]
2. Analytical applications of partitioning in aqueous two-phase systems: Exploring protein structural changes and protein-partner interactions in vitro and in vivo by solvent interaction analysis method.
Zaslavsky BY; Uversky VN; Chait A
Biochim Biophys Acta; 2016 May; 1864(5):622-44. PubMed ID: 26923390
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
4. Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies.
Silva ML
Biochim Biophys Acta; 2015 Dec; 1856(2):165-77. PubMed ID: 26232626
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation Changes in Serum Proteins Identify Patients with Pancreatic Cancer.
Drabik A; Bodzon-Kulakowska A; Suder P; Silberring J; Kulig J; Sierzega M
J Proteome Res; 2017 Apr; 16(4):1436-1444. PubMed ID: 28244758
[TBL] [Abstract][Full Text] [Related]
6. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
[TBL] [Abstract][Full Text] [Related]
7. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
8. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
9. Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.
Pernikářová V; Bouchal P
Expert Rev Proteomics; 2015; 12(6):651-67. PubMed ID: 26456120
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of human plasma for cancer biomarker discovery.
Huang Z; Ma L; Huang C; Li Q; Nice EC
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27550791
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
Mermelekas G; Zoidakis J
Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Wang C; Fang X; Lee CS
Methods Mol Biol; 2013; 984():1-12. PubMed ID: 23386332
[TBL] [Abstract][Full Text] [Related]
14. Mining the plasma proteome for cancer biomarkers.
Hanash SM; Pitteri SJ; Faca VM
Nature; 2008 Apr; 452(7187):571-9. PubMed ID: 18385731
[TBL] [Abstract][Full Text] [Related]
15. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
16. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
17. Glycocapture-based proteomics for secretome analysis.
Lai ZW; Nice EC; Schilling O
Proteomics; 2013 Feb; 13(3-4):512-25. PubMed ID: 23197367
[TBL] [Abstract][Full Text] [Related]
18. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
Clarke W; Chan DW
Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
[No Abstract] [Full Text] [Related]
19. Cancer: a proteomic disease.
Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
[TBL] [Abstract][Full Text] [Related]
20. Applications of diagonal chromatography for proteome-wide characterization of protein modifications and activity-based analyses.
Gevaert K; Impens F; Van Damme P; Ghesquière B; Hanoulle X; Vandekerckhove J
FEBS J; 2007 Dec; 274(24):6277-89. PubMed ID: 18021238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
